[go: up one dir, main page]

MX2010001482A - Proteinas de streptococcus inmunogenicas. - Google Patents

Proteinas de streptococcus inmunogenicas.

Info

Publication number
MX2010001482A
MX2010001482A MX2010001482A MX2010001482A MX2010001482A MX 2010001482 A MX2010001482 A MX 2010001482A MX 2010001482 A MX2010001482 A MX 2010001482A MX 2010001482 A MX2010001482 A MX 2010001482A MX 2010001482 A MX2010001482 A MX 2010001482A
Authority
MX
Mexico
Prior art keywords
proteins
immunogenic
streptococcus
eliciting
immune response
Prior art date
Application number
MX2010001482A
Other languages
English (en)
Inventor
Hilda Elizabeth Smith
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of MX2010001482A publication Critical patent/MX2010001482A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)

Abstract

La invención proporciona medios y métodos para identificar una proteína de Streptococcus que es capaz de obtener una respuesta inmunogénica contra al menos dos cepas y/o serotipos de Streptococcus. La invención además describe composiciones inmunogénicas capaces de obtener una respuesta inmunogénica contra Streptococcus uberis que comprende al menos dos proteínas recombinantes y/o aisladas derivadas de Streptococcus uberis, y/o una parte inmunogénica o análogo o derivado de ya sea cualquiera o ambas de las proteínas. La invención además describe moléculas de ácido nucleico que codifican las proteínas o partes inmunogénicas del mismo, células hospederas y portadores recombinantes que comprenden tal molécula de ácido nucleico, y vacunas y pruebas &e diagnóstico basadas en las proteínas y ácidos nucleicos.
MX2010001482A 2007-08-06 2008-08-05 Proteinas de streptococcus inmunogenicas. MX2010001482A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113844A EP2023143A1 (en) 2007-08-06 2007-08-06 Immunogenic streptococcus proteins
PCT/NL2008/050537 WO2009020391A1 (en) 2007-08-06 2008-08-05 Immunogenic streptococcus proteins

Publications (1)

Publication Number Publication Date
MX2010001482A true MX2010001482A (es) 2010-03-01

Family

ID=38890252

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001482A MX2010001482A (es) 2007-08-06 2008-08-05 Proteinas de streptococcus inmunogenicas.

Country Status (19)

Country Link
US (1) US20100297183A1 (es)
EP (3) EP2023143A1 (es)
JP (2) JP5462164B2 (es)
KR (1) KR20100063706A (es)
CN (1) CN101821627A (es)
AR (1) AR067830A1 (es)
AU (1) AU2008284491A1 (es)
BR (1) BRPI0815604A2 (es)
CA (1) CA2695721A1 (es)
CL (1) CL2008002320A1 (es)
CO (1) CO6270172A2 (es)
DK (1) DK2183597T3 (es)
ES (1) ES2432407T3 (es)
MX (1) MX2010001482A (es)
RU (1) RU2518315C2 (es)
TW (1) TW200911999A (es)
UA (1) UA103885C2 (es)
WO (1) WO2009020391A1 (es)
ZA (1) ZA201000806B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228700B1 (en) 1998-07-22 2013-05-28 Stichting Dienst Landbouwkundi Streptococcus suis vaccines and diagnostic tests
DE60239858D1 (de) 2001-02-02 2011-06-09 Stichting Dienst Landbouwkundi Umwelt-regulierte gene, welche an der virulenz von streptococcus suis beteiligt sind
GB0818231D0 (en) 2008-10-06 2008-11-12 Univ Nottingham Composition
KR20190009840A (ko) * 2013-09-19 2019-01-29 조에티스 서비시즈 엘엘씨 유성 아쥬반트
JP2018504381A (ja) * 2014-12-22 2018-02-15 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 細胞透過性ペプチド
WO2017068112A1 (en) 2015-10-21 2017-04-27 Minervax Aps Immunogenic fusion protein
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
RU2685957C2 (ru) * 2016-12-28 2019-04-23 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes
IL301666A (en) * 2020-12-23 2023-05-01 Chan Zuckerberg Biohub Inc Bacteria-engineered to produce antigen-specific T cells
CN112773891B (zh) * 2021-02-01 2022-03-25 北部湾大学 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用
CN119219752A (zh) * 2024-09-12 2024-12-31 华中农业大学 一种猪链球菌抗原蛋白及其筛选方法及其应用
CN119780429B (zh) * 2024-12-27 2025-12-26 华派生物技术(集团)股份有限公司 一种提高猪圆环病毒2型Cap蛋白抗原琼扩检测灵敏度的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283507A (en) 1990-12-20 1994-02-01 General Electric Company Regenerative braking protection for an electrically-propelled traction vehicle
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
AU2638595A (en) * 1994-05-16 1995-12-05 Uab Research Foundation, The (streptococcus pneumoniae) capsular polysaccharide genes and flanking regions
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750042A1 (fr) * 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
AU738649B2 (en) 1996-04-26 2001-09-20 Rijksuniversiteit Te Leiden Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
HU228700B1 (en) * 1998-07-22 2013-05-28 Stichting Dienst Landbouwkundi Streptococcus suis vaccines and diagnostic tests
JP4689044B2 (ja) * 1998-12-21 2011-05-25 メディミューン，インコーポレーテッド ワクチン用の肺炎連鎖球菌タンパク質と免疫原断片
DK1409654T3 (da) * 1999-06-16 2008-12-08 Boston Biomedical Res Inst Immunologisk styring af beta-amyloid-niveauer in vivo
EP1294771B1 (en) * 2000-06-12 2008-10-29 University Of Saskatchewan Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
DE60239858D1 (de) * 2001-02-02 2011-06-09 Stichting Dienst Landbouwkundi Umwelt-regulierte gene, welche an der virulenz von streptococcus suis beteiligt sind
EP1572975B1 (en) * 2002-11-26 2014-07-16 University Of Tennessee Research Foundation Streptococcus uberis adhesion molecule
EP1590368B1 (en) * 2003-01-27 2014-02-26 Københavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
EP1629005A2 (en) * 2003-05-30 2006-03-01 Intercell AG Enterococcus antigens
WO2006048763A1 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
PT2029173T (pt) * 2006-06-26 2016-11-02 Macrogenics Inc Anticorpos específicos fc rib e seus métodos de uso

Also Published As

Publication number Publication date
EP2660604A3 (en) 2014-02-12
AR067830A1 (es) 2009-10-21
CN101821627A (zh) 2010-09-01
US20100297183A1 (en) 2010-11-25
EP2183597A1 (en) 2010-05-12
BRPI0815604A2 (pt) 2015-03-03
ZA201000806B (en) 2010-10-27
AU2008284491A1 (en) 2009-02-12
EP2660604A2 (en) 2013-11-06
CL2008002320A1 (es) 2009-09-25
JP5462164B2 (ja) 2014-04-02
ES2432407T3 (es) 2013-12-03
RU2010107878A (ru) 2011-09-20
CO6270172A2 (es) 2011-04-20
EP2183597B1 (en) 2013-07-24
EP2023143A1 (en) 2009-02-11
UA103885C2 (en) 2013-12-10
JP2014095721A (ja) 2014-05-22
RU2518315C2 (ru) 2014-06-10
JP2010535500A (ja) 2010-11-25
WO2009020391A1 (en) 2009-02-12
DK2183597T3 (da) 2013-10-14
TW200911999A (en) 2009-03-16
CA2695721A1 (en) 2009-02-12
KR20100063706A (ko) 2010-06-11

Similar Documents

Publication Publication Date Title
MX2010001482A (es) Proteinas de streptococcus inmunogenicas.
BRPI0707154B8 (pt) composição de vacina
BRPI0614761A2 (pt) proteìnas de fusão de albumina
EP1219711A3 (en) Lawsonia intracellularis vaccine
EP1917033A4 (en) VIRUS LIKE PARTICLES AS PARAMYXOVIRUS VACCINES
WO2007106476A3 (en) Compositions and methods for enhancing the immunogenicity of antigens
WO2008127179A8 (en) Fusion protein vaccine
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
DK2054431T3 (da) Konformere af bakterielle adhæsiner
WO2005070958A3 (en) Lawsonia intracellularis subunit vaccines
WO2008127094A3 (en) New virulence factors of streptococcus pnuemoniae
WO2005026200A3 (en) Lawsonia intracellularis subunit vaccine
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
BRPI1014505A8 (pt) Proteína de fusão de múltiplos epítopos, método para produzir uma composição, polinucleotídeo, vetor recombinante, célula hospedeira, método para produzir uma proteína de fusão de múltiplos epítopos, kit de teste imunodiagnóstico, composição, e, uso de uma proteína de fusão de múltiplos epítopos
WO2013138259A3 (en) Polypeptides for treating and/or limiting influenza infection
WO2008002548A3 (en) Novel human acidic mammalian chitinase and use thereof
WO2006113782A3 (en) Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
WO2005026199A3 (en) Piroplasmid vaccine
WO2008076490A3 (en) Histophilus somni antigens, compositions and methods of use
WO2010041938A3 (en) New virulence factors of streptococcus pneumoniae
TH127963A (th) โปรตีนของ Streptococcus ที่ก่อภูมิคุ้มกัน
Ruan et al. Identification on the immunogenic activity of recombinant rLTB/CTB-LipL41/1 to Leptospira interrogans and detection of lipL41 gene with its production
HK1158087A (en) New virulence factors of streptococcus pneumoniae

Legal Events

Date Code Title Description
FG Grant or registration